According to the researchers, a vaccine named Provenge has shown promise in prolonging life for men battling a deadly cancer that affects over 200,000 men a year and kills about 27,000. The study involved 500 men with an advanced form of prostrate cancer and according to Dr. Jennifer Ashton , half of them were treated with a placebo , while the other half were treated with Provenge.

Ashton explained, "Those treated with the vaccine had what was found to be a significantly increased life expectancy or survival, However that was four months. So it took them average from 22 months survival to 26 months survival." She added, "This form of treatment is different and "uses the patient's own blood cells to trick the tumor cells in to stimulating the body's own immune system to attack that tumor.". It may also be noted that these are personalized vaccines and so that marked the tumor more complicated and expensive to make however the patient will reap the benefits in treatment.

Prostrate Cancer traditionally is treated with Chemotherapy, surgery or radiation therapy, all of which have major risks. Ashton adds, "The exciting thing about this vaccine is this is thought to be by many cancer experts as the future in cancer treatment. Personalized treatment and therapy that targets only the tumor, and not the rest of the body. So we're going to have to wait and see."